Together we work on research
for the medicine of the future

Projects Carousel

Detailed recordings are being made of a study participant's movements in a laboratory.

Mobility for stroke and Parkinson’s patients

Institutions involved
4
Team size
15
External funding sources
1
External funding

in CHF millions

5
In the operating theatre

Highly innovative technology revolutionizes spinal operations

Institutions involved
4
Team size

>

10
External funding sources
1
External funding

in CHF millions

1

Keeping track of stress

Institutions involved
4
Team size
45
External funding sources
2
External funding

in CHF millions

1

Personalized treatment of urinary tract infections

Institutions involved
4
Team size
25
External funding sources
1
External funding

in CHF millions

5

Hard on the heels of tumors

Institutions involved
3
Team size
100

Research brings hope for children with aggressive brain tumors

Institutions involved
4
Team size
16
External funding sources
5
External Funding

in CHF millions

>5

Gut bacteria: the smart helper in the fight against cancer

Institutions involved
2
Team size
10
External funding sources
1
External funding

in CHF millions

1.65

Bacteria-eaters combat bladder infections

Institutions involved
4
Team size

>

15
External funding sources
1
External funding

in CHF millions

1
Working with the support of a pipetting robot

Precision medicine for children and adults with blood cancer

Institutions involved
4
Team size

>

15
External funding sources
1
External funding

in CHF millions

5

Precision medicine to combat obesity

Institutions involved
3
Team size
25
External funding sources
1
External Funding

in CHF millions

5

Robots with a deft touch

Institutions involved
2
Team size
40
External funding sources
1
External Funding

in EUR millions

3
Detailed recordings are being made of a study participant's movements in a laboratory.

Mobility for stroke and Parkinson’s patients

Institutions involved
4
Team size
15
External funding sources
1
External funding

in CHF millions

5
In the operating theatre

Highly innovative technology revolutionizes spinal operations

Institutions involved
4
Team size

>

10
External funding sources
1
External funding

in CHF millions

1

Keeping track of stress

Institutions involved
4
Team size
45
External funding sources
2
External funding

in CHF millions

1

Personalized treatment of urinary tract infections

Institutions involved
4
Team size
25
External funding sources
1
External funding

in CHF millions

5

Discover Projects

Data in Precision Medicine

New developments in medicine are coming thick and fast. Technological advances are increasingly making it possible to understand diseases and the processes taking place in the human body down to the level of individual genes and cells. This brings definite benefits for patients. The earlier an accurate diagnosis can be made and the more precisely a disease can be treated, the greater the prospects of a cure or an improvement in the patient’s quality of life. Nowadays, treatments can be tailored to individual patients more and more effectively. This is what is known as precision medicine and the pioneering field in this area is oncology. We now know that every tumor is unique. If we can analyze the genome of tumor cells, for example, we will have a better chance of making a targeted attack on their weak points.

Gene analyses of this kind and other modern diagnostic methods produce large volumes of data. Artificial intelligence makes it easier to evaluate these data and, for instance, to detect patterns that indicate why diseases occur. Therefore, the hope is that it will be possible in the future to prevent, diagnose and treat many diseases much more effectively than in the past.

The growing volume of data in the field of medicine must be used in order to achieve this. The central elements of this process are the interdisciplinary cooperation between researchers at the interfaces to medicine – for example from the fields of informatics, biomedicine and law – and the involvement of the patients, because we can only shape the medicine of the future by working together as a society. To gain a better understanding of the accompanying opportunities, we have shone a spotlight on different aspects of this subject. They range from a common platform for data sharing to groundbreaking new technologies and questions of ethics and data protection.

Successfully Closing the Gap from Research to the Market

Those looking to found a spin-off based on a medical innovation will find excellent conditions in Zurich. Researchers benefit from the outstanding infrastructure at the universities and the advantages of the region as a business hub. University Medicine Zurich is a driving force in this dynamic innovation landscape. Through the Translational Medicine Accelerator (TMA), it offers tailored support to accelerate the development of marketable applications or products from research results. Additionally, the TMA provides a valuable network that connects industry and investors. This commitment contributes sustainably to strengthening the region by creating highly qualified jobs and improving healthcare – even on a global scale.

Numerous spin-offs in Zurich demonstrate how the step into entrepreneurship can succeed. With targeted support, they have brought their medical innovations to market. Our series showcases some of these successes.

Successfully Closing the Gap from Research to the Market

Those looking to found a spin-off based on a medical innovation will find excellent conditions in Zurich. Researchers benefit from the outstanding infrastructure at the universities and the advantages of the region as a business hub. University Medicine Zurich is a driving force in this dynamic innovation landscape. Through the Translational Medicine Accelerator (TMA), it offers tailored support to accelerate the development of marketable applications or products from research results. Additionally, the TMA provides a valuable network that connects industry and investors. This commitment contributes sustainably to strengthening the region by creating highly qualified jobs and improving healthcare – even on a global scale.

Numerous spin-offs in Zurich demonstrate how the step into entrepreneurship can succeed. With targeted support, they have brought their medical innovations to market. Our series showcases some of these successes.

Translational Medicine Accelerator (TMA)

Zurich offers ideal conditions for spin-offs

To help close the gap between scientific research and use in practice, UMZH is offering interested spin-offs an opportunity to improve their competitiveness with the Translational Medicine Accelerator (TMA).

OBaris

Pain-free alternative for administering medication

With their «OctoPatch» suction cup, Nevena Paunović and David Klein Cerrejon want to revolutionize how people take their medication. Their spin-off, known as «OBaris», is about to enter its first clinical study.

OxyPrem

Oxygen Sensor for Premature BabiesPain-free alternative for administering medication

Each year, some 6,000 to 7,000 babies are born prematurely in Switzerland. This equates to around eight percent of all deliveries. These early arrivals often suffer from a lack of oxygen. The start-up known as OxyPrem has developed a device that accurately measures oxygen levels and can therefore help save lives.

Navignostics

Precision diagnostics for tumor diseases

Together with three partners, Jana Fischer has taken the bold step of founding a company and entering the world of private enterprise. The tumor diagnostics services offered by her company «Navignostics» will be available in Switzerland from 2025 and will help treatment providers make better-informed decisions.

List view
Selected projects
Research Centers